S. Uruba

Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials.

O. Margalit, R. Wolff, Lianchun Xiao, 2021, JAMA oncology.